The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic correlates of extreme pathologic response following neoadjuvant chemotherapy in locally advanced gastric cancer to reveal distinct vulnerabilities.
 
Jashodeep Datta
No Relationships to Disclose
 
Henry S. Walch
No Relationships to Disclose
 
Ashley Russo
No Relationships to Disclose
 
Walid Khaled Chatila
No Relationships to Disclose
 
Elvira Vos
No Relationships to Disclose
 
Umesh Bhanot
No Relationships to Disclose
 
Yelena Yuriy Janjigian
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Jounce Therapeutics; Jounce Therapeutics; Jounce Therapeutics; Jounce Therapeutics; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Michael J. Hennessy Associates; Michael J. Hennessy Associates; Michael J. Hennessy Associates; Michael J. Hennessy Associates; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Pfizer; Pfizer; Pfizer; Pfizer; Rgenix; Rgenix; Rgenix; Rgenix
Research Funding - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Genentech; Genentech; Genentech; Genentech; Lilly; Lilly; Lilly; Lilly; Roche; Roche; Roche; Roche
 
Nikolaus Schultz
No Relationships to Disclose
 
Laura H. Tang
No Relationships to Disclose
 
Vivian E. Strong
No Relationships to Disclose